Effect of Pharmaceutical Interventions Targeting Thromboxane Receptors and Thromboxane Synthase in Cardiovascular and Renal Diseases
Kjell S. Sakaríassen(Ospedale degli Infermi), Alexandra Santana Sorensen(Evolva (Switzerland)), Henri Bounameaux(University of Geneva), Pēteris Alberts(Maxygen (United States)), Pierre Fontana(Université de Montpellier), Jessica Mann(BH Consulting (Ireland))
Cited by 26
Related Papers
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2003|809
Thalassemia Syndromes
|Unknown|2009|475
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263